{
  "docId": "019dd923-5e88-73ef-bd5d-06b04d219fea",
  "docSlug": "dd91c78f6570bf29",
  "documentTitle": "2023 Air Street Capital The State of AI Report 2023",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 102,
  "pageCount": 163,
  "prevPage": 101,
  "nextPage": 103,
  "slideType": "client_example",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses press release snippets to validate the trend of AI adoption in pharma.",
  "elementsJson": [
    "headline_text",
    "action_title",
    "bullet_list",
    "screenshot",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-06b04d219fea/102",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-06b04d219fea",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-06b04d219fea.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-06b04d219fea#slide-102",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "mRNA vaccine leader, BioNTech acquired AI company InstaDeep for €500M, while Sanofi goes “all in” on AI, Merck enters into new deals with AI-first drug company, Exscientia, worth up to $674M and AstraZeneca partners with Verge Genomics in a deal worth up to $840M.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a22a-4f7448355e8f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.5,
        "y": 0.68
      },
      "kind": "image",
      "text": "AstraZeneca/Verge Genomics partnership details",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ba21600-95d7-49b0-a3f6-ba0b50687486",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.5,
        "y": 0.38
      },
      "kind": "image",
      "text": "BioNTech/InstaDeep acquisition summary",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1eaa165e-519e-40f1-9a9c-1bdad577999a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.38
      },
      "kind": "image",
      "text": "Sanofi press release snippet",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "278ef7c7-5e4c-4bed-99f7-50c1d7e1b7e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.05,
        "y": 0.68
      },
      "kind": "image",
      "text": "Exscientia/Merck announcement",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30dd5b92-3e42-4fee-9e00-1989cc93e825",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "list",
      "text": "mRNA vaccine leader, BioNTech acquired AI company InstaDeep for €500M, while Sanofi goes “all in” on AI, Merck enters into new deals with AI-first drug company, Exscientia, worth up to $674M and AstraZeneca partners with Verge Genomics in a deal worth up to $840M.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54661a58-6dc7-48a5-8281-d4b9edcc6065",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Deal value: $840m",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a22a-54af38dce668",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. - Paul Hudson, CEO, Sanofi",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a22a-53ee19147ffd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "Once ignored by major pharma companies, AI is moving front and center for some",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b50efd6-6401-4722-a1d2-2d3b6905852e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "3fd6f4b9-94ea-481f-91be-ead4135d87ee",
      "evidence": "The slide presents information in a list/bullet format, listing several companies and their deals, which is a clear example of a list presentation.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 120,
      "from": 11,
      "beatId": "019dd95a-0682-776c-8e35-41afd44ef59f",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Research + Industry sections inventory model, compute, funding facts.",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 120,
      "from": 11,
      "beatId": "019dd95a-0682-776c-8e35-523bfb7f96e6",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Rising Action",
      "beatSlug": "mountain-rising-action",
      "evidence": "Escalating capabilities, compute concentration and capital flows.",
      "position": 2,
      "confidence": 45,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 120,
      "from": 99,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3e-09a2221c6f1a",
      "evidence": "Funding, valuations, geo split, unicorns, sector mix, M&A, CVC, GenAI rounds compound the same thesis.",
      "position": 11,
      "objective": "Map the GenAI investment surge across stages, geos and corporates",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 80,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}